October 24, 2014 4:40 AM ET


Company Overview of Envisia Therapeutics Inc.

Company Overview

Envisia Therapeutics Inc. is engaged in the discovery and development of ocular therapeutics for the critical needs in ophthalmology. The company offers ENV515, a prostaglandin analogue that uses a biodegradable PRINT particle formulation to provide sustained intraocular pressure reduction over months. It also provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic, chemical, or other barriers that limit existing ocular therapies; therapeutics based on biocompatible polymers for the delivery of medicines with extended-release kinetics; and topical therapies for treating ocular diseases. The company was founded in 2013 and is based in Morrisville, North ...

419 Davis Drive

Suite 100

Morrisville, NC 27560

United States

Founded in 2013





Key Executives for Envisia Therapeutics Inc.

Chief Executive Officer and Director
Age: 52
Chief Financial Officer
Chief Medical Officer
Vice President of Corporate Development
Chief Scientific Officer
Age: 48
Compensation as of Fiscal Year 2014.

Envisia Therapeutics Inc. Key Developments

Envisia Therapeutics Announces Appointments to Board of Directors

Envisia Therapeutics announced that it has made two appointments to the company's board of directors. Effective immediately, Adrienne Graves, Ph.D. and Gary Phillips, M.D. will join the board as non-executive members. Dr. Graves was formerly President and Chief Executive Officer of Santen USA, a division of Santen Co. Ltd. Dr. Gary Phillips has more than 20 years' experience in strategy, business development and licensing, commercial operations, business analytics, and clinical medicine in the pharmaceutical and healthcare industries. He is currently the Senior Vice President and Chief Strategy Officer at Mallinckrodt Pharmaceuticals.

Envisia Therapeutics Inc. Presents at 2014 Leerink Swann Global Healthcare Conference, Feb-12-2014 01:25 PM

Envisia Therapeutics Inc. Presents at 2014 Leerink Swann Global Healthcare Conference, Feb-12-2014 01:25 PM. Venue: The Waldorf Astoria Hotel, New York, New York, United States. Speakers: Neal F. Fowler, Chief Executive Officer and Director.

Similar Private Companies By Industry

Company Name Region
CeraPedics, Inc. United States
PeptiVir, Inc. United States
Leonard-Meron Biosciences, Inc. United States
Calcigen Corporation United States
Enobia Pharma Corp. United States

Recent Private Companies Transactions

Private Placement
November 8, 2013

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Envisia Therapeutics Inc., please visit www.envisiatherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.